MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

STERIS PLC

Fermé

SecteurSoins de santé

227.86 1.11

Résumé

Variation du prix de l'action

24h

Actuel

Min

222.03

Max

228.11

Chiffres clés

By Trading Economics

Revenu

16M

173M

Ventes

42M

1.4B

P/E

Moyenne du Secteur

36.498

63.778

BPA

2.32

Rendement du dividende

1.01

Marge bénéficiaire

12.643

Employés

18,000

EBITDA

-85M

245M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+17.4% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

1.01%

2.39%

Prochains Résultats

7 mai 2025

Date du Prochain Dividende

25 juin 2025

Date du Prochain Détachement de Dividende

11 juin 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

22B

Ouverture précédente

226.75

Clôture précédente

227.86

Sentiment de l'Actualité

By Acuity

26%

74%

73 / 386 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Bearish Evidence

STERIS PLC Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

5 févr. 2025, 21:35 UTC

Résultats

Steris: Outlook Does Not Reflect Any Potential Impact From New Tariffs >STE

5 févr. 2025, 21:34 UTC

Résultats

Steris: FY25 Guidance Change Is Primarily Due to Currency >STE

5 févr. 2025, 21:34 UTC

Résultats

Steris Cuts FY25 Revenue View to Increase of About 6% From Prior View for 6.5%-7%>STE

5 févr. 2025, 21:33 UTC

Résultats

Steris 3Q EPS $1.75 >STE

5 févr. 2025, 21:30 UTC

Résultats

Steris Sees FY Adj EPS $9.05-Adj EPS $9.15 >STE

5 févr. 2025, 21:30 UTC

Résultats

Steris 3Q Rev $1.4B >STE

5 févr. 2025, 21:30 UTC

Résultats

Steris 3Q Adj EPS $2.32 >STE

6 nov. 2024, 21:41 UTC

Résultats

Steris Backs FY25 Revenue Up 6.5%-7.5% >STE

6 nov. 2024, 21:40 UTC

Résultats

Steris 2Q EPS $1.51 >STE

6 nov. 2024, 21:30 UTC

Résultats

Steris Sees FY Adj EPS $9.05-Adj EPS $9.25 >STE

6 nov. 2024, 21:30 UTC

Résultats

Steris 2Q Adj EPS $2.14 >STE

6 nov. 2024, 21:30 UTC

Résultats

Steris 2Q Rev $1.3B >STE

6 août 2024, 20:36 UTC

Résultats

Steris 1Q Adj EPS $2.03 >STE

6 août 2024, 20:30 UTC

Résultats

Steris 1Q Net $139.9M >STE

6 août 2024, 20:30 UTC

Résultats

Steris 1Q EPS $1.41 >STE

6 août 2024, 20:30 UTC

Résultats

Steris Sees FY Adj EPS $9.05-Adj EPS $9.25 >STE

3 juin 2024, 11:03 UTC

Acquisitions, Fusions, Rachats

PEAK ROCK Cap Affil COMPLETES PREVIOUSLY ANNOUNCED ACQUISITION of HUFRIEDYGROUP

31 mai 2024, 20:47 UTC

Acquisitions, Fusions, Rachats

Steris Completes $787.5M Sale of Dental Segment to Peak Rock Capital

8 mai 2024, 20:40 UTC

Résultats

Steris Sees FY25 Adj EPS $9.05-Adj EPS $9.25 >STE

8 mai 2024, 20:39 UTC

Résultats

Steris: Plan Includes Restructuring of the Healthcare Surgical Business in Europe >STE

8 mai 2024, 20:39 UTC

Résultats

Steris Announcing a Targeted Restructuring Plan >STE

8 mai 2024, 20:39 UTC

Résultats

Steris 4Q EPS $3.81 >STE

8 mai 2024, 20:30 UTC

Résultats

Steris 4Q Adj EPS $2.58 >STE

11 avr. 2024, 11:01 UTC

Acquisitions, Fusions, Rachats

Steris Expects Resulting Benefit of Reduction in Interest Expense to Be About $0.35 Per Shr >STE

11 avr. 2024, 11:00 UTC

Acquisitions, Fusions, Rachats

Steris: Transaction Is Anticipated to Close in 1Q of Fiscal Yr 2025 >STE

11 avr. 2024, 10:59 UTC

Acquisitions, Fusions, Rachats

Steris: Transaction Terms Include Opportunity to Receive Additional Earnout of Up to $12.5M >STE

11 avr. 2024, 10:59 UTC

Acquisitions, Fusions, Rachats

Steris: Transaction Is Structured as Equity Sale >STE

11 avr. 2024, 10:58 UTC

Acquisitions, Fusions, Rachats

Steris Enters Agreement to Divest Dental Segment to Peak Rock Cap for $787.5M >STE

11 avr. 2024, 10:58 UTC

Acquisitions, Fusions, Rachats

STERIS to Sell Dental Segment to an Affiliate of Peak Rock Capital for $787.5M

Comparaison

Variation de prix

STERIS PLC prévision

Objectif de Prix

By TipRanks

17.4% hausse

Prévisions sur 12 Mois

Moyen 265 USD  17.4%

Haut 265 USD

Bas 265 USD

Basé sur 3 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

3 ratings

2

Achat

1

Maintien

0

Vente

Score Technique

By Trading Central

224.21 / 226.14Support & Résistance

Court Terme

Bearish Evidence

Moyen Terme

Strong Bullish Evidence

Long Terme

Weak Bullish Evidence

Sentiment

By Acuity

73 / 386Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos STERIS PLC

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.